towards acceleration of drug development, an extremely exciting and promising emerging application of our models
OpenAI acquires Orchestra Bio to speed up drug development
AIOpenAI has acquired Orchestra Bio, a platform that helps biopharma teams coordinate drug development. The companies plan to build on Rosalind, OpenAI's AI models and tools for life sciences research, to streamline operations and help new treatments reach patients sooner.
@gdb
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/View quoted post on X
This story is featured in top picks: “OpenAI acquires Orchestra Bio to coordinate biopharma drug development”
Source details
Greg Brockman · x.comPublished
Original title: towards acceleration of drug development, an extremely exciting and promising emerging application of our models